Award
National Institute of Allergy and Infectious Diseases 5R21AI186028-02
Myeloid cell TRAF6 signaling in SARS-CoV-2-induced dysregulated lung immunity
Recipient
Oklahoma State University Stillwater
Award Amount
$184,519.00
Ceiling
$184,519.00
Awarded
May 13, 2025
Identifier
5R21AI186028-02
Award for research on the role of myeloid cell TRAF6 signaling in SARS-CoV-2-induced lung disease, funded by NIH/NIAID with an amount of $184,519.
Description
The project focuses on the role of myeloid cell-intrinsic TLR-TRAF6 activation in causing SARS-CoV-2-induced lethal lung disease. It involves research on dysregulated immunity, lung inflammation, and potential therapeutics targeting TRAF6. The award amount is approximately $184,519 with a budget period from May 1, 2025, to April 30, 2027.